Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
28 Patents
#65 in Los Angeles, CA
#2,850 in California
#12,022 in US
#23,317 in the World
Cytrx Corporation
Forward Citations = 438
52 inventors:
Los Angeles, CA, United States of America
Cytrx Corporation
Calculating rank
% Expired Patents = 32.1
CIPO Patents = 2
EPO Patents = 2
Trademarks = 2
Forward Citations = 438
Loading Chart...
Loading Chart...
52 inventors (with patents filed for the assignee):
R Martin Emanuele (16 out of 29 patents)
Mannarsamy Balasubramanian (9 out of 16 patents)
Robert L Hunter (9 out of 43 patents)
4. Paula H Culbreth (8 out of 8 patents)
5. László Ürögdi (7 out of 15 patents)
6. Ede Márványos (6 out of 12 patents)
7. Carlos A Rivera-Marrero (5 out of 5 patents)
8. Charles William Todd (5 out of 5 patents)
9. Robert Newton Brey, Iii (5 out of 5 patents)
10. Mark Joseph Newman (5 out of 12 patents)
11. Zita Jegesné Csákai (4 out of 4 patents)
12. Magdolna Bathóné Török (4 out of 4 patents)
13. László Dénes (4 out of 4 patents)
14. Daniel Levitt (3 out of 3 patents)
15. László Vígh (2 out of 4 patents)
Core Competencies:
Cytotoxic Agents
Cancer Treatment
Anthracycline Formulations
Vaccine Adjuvants
Biologically Active Copolymers
Molecular Chaperones
Carboxamidine Derivatives
Pharmaceutically Effective Compounds
Growth Promotion
Antiinfective Copolymers
Microbial Binding Inhibition
Gel Composition
28 patents:
5. 7691849 - Carboxamidine derivatives and their use in the treatment of vascular diseases (2010-04-06),
7. 7384936 - Carboxamidine derivatives and their use in the treatment of vascular diseases (2008-06-10),
13. RE38558 - Polyoxypropylene/polyoxyethylene copolymers with improved biological activity (2004-07-20),
Company Overview
Cytrx Corporation is a biopharmaceutical company based in Los Angeles, California, focused on the development of innovative therapies for the treatment of cancer and other serious diseases. The company specializes in leveraging its proprietary drug delivery technologies to enhance the efficacy and safety of existing therapies. With a commitment to advancing medical science, Cytrx aims to address unmet medical needs through its research and development efforts, contributing to the evolving landscape of biopharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytrx Corporation. Retrieved from https://idiyas.com/company/cytrx
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]